Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dyne Therapeutics, Inc.

9.40
-0.6200-6.19%
Post-market: 9.700.2997+3.19%19:55 EDT
Volume:5.56M
Turnover:52.39M
Market Cap:1.07B
PE:-2.79
High:10.12
Open:10.10
Low:9.17
Close:10.02
Loading ...
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 19, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 19, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities